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Phosphorylation of β-catenin, a central downstream
component of the Wnt pathway, by glycogen syn-
thase kinase 3 is essential for its targeted degrada-
tion by the proteosome. New studies show that
casein kinase 1 primes β-catenin for subsequent
phophorylation by glycogen synthase kinase 3.
As with any other signaling system, our picture of the
Wnt pathway undergoes continuous modification and
refinement as new and surprising discoveries are
made. Accordingly, a couple of years ago the Wnt
field received a jolt when two groups announced that
casein kinase 1ε (CKIε) is a positive transducer of the
signal [1,2]. This knowledge spawned several addi-
tional reports on the regulation of Wnt signaling by
CKIε, each advancing a different mechanism by which
this regulation is achieved [3–7]. Nevertheless, with
the exception of one study to the contrary [7], all were
consistent in arguing that CKIε plays a positive role in
the Wnt pathway. Now it appears that the pendulum
has swung with the release of three new papers [8–10]
all proposing a similar mechanism for a negative role
of CKI in the Wnt pathway.
A cursory review of Wnt signaling is essential for
understanding these studies. The secreted Wnt ligands
activate serpentine receptors which transmit signals
leading to the stabilization of the β-catenin protein
(Figure 1). Once stabilized, β-catenin engages tran-
scription factors of the LEF/TCF family to activate
various genes controlling cell growth and differentia-
tion. A complex of proteins united by Axin occupies
the space between receptor ligation and β-catenin
stabilization. Axin binds to APC, β-catenin, glyocygen
synthase kinase 3 (GSK3), protein phosphatase 2Ac
(PP2Ac), Dishevelled and CKI. Two of these mole-
cules, Axin and APC, are products of bona fide human
tumor suppressor genes, and a third, β-catenin, is
encoded by a proto-oncogene [11]. APC and Axin are
intimately involved in processing of β-catenin for
recognition by an E3 ubiquitin ligase containing the F-
box protein β-TRCP. Thus, appropriate defects in
APC, Axin or β-catenin interfere with the targeted
destruction of β-catenin by the proteosome, thereby
prolonging its signaling capacity.
At the heart of the matter is the phosphorylation of
specific serine and threonine residues in the amino-
terminal region of β-catenin. Phosphorylation of these
residues is essential for β-catenin binding to β-TRCP,
and mutations affecting them are found in a variety of
human tumors [11]. It had been presumed for many
years that GSK3 catalysed these key phosphoryla-
tions, and that they were somehow interfered with by
Wnt signaling [12]. The discovery of a GSK3-binding
protein (GBP) that disrupted the association of GSK3
with Axin, and also bound to Dishevelled, conformed
nicely with the prevailing model [13]. The target
serines and threonines in β-catenin, each separated
by three intervening residues, conform to consensus
motifs for GSK3, and it was recently shown that Wnt
signaling indeed modulates their phosphorylation [14].
Lurking in the shadows, however, was the complica-
tion that many GSK3 substrates require priming by
another kinase that phosphorylates a serine/threonine
four residues downstream of the GSK3 site. It was
therefore proposed that the simultaneous binding of
GSK3 and β-catenin to Axin might obviate the require-
ment for such priming [15]. After all, addition of Axin to
test tubes containing β-catenin and GSK3 accelerated
the rate of β-catenin phosphorylation [16].
The three new papers [8–10] on CKI illuminate the
once shadowy area and make it clear that GSK3 does
not act alone in setting up β-catenin for the kill. Although
some differences exist between the results reported in
these papers, all concur that serine 45 in β-catenin is
phosphorylated by a CKI, and that this likely serves as
a priming site for subsequent phos-phorylations by
GSK3. Two reagents have made these discoveries
possible — antibodies specific to sites of β-catenin
phosphorylation, and RNA-mediated interference (RNAi).
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Figure 1. The Wnt signaling pathway.
Signaling is initiated by binding of Wnt to the cell surface
receptor Frizzled. Arrowheads and bars indicate activating and
inhibitory signals, respectively. Green and red rectangles signify
positive and negative acting components in the pathway that
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Lui et al. [9] generated antiserum specific to β-catenin
serine 45 and showed that phosphorylation at this site
was stimulated by the expression of an Axin fragment
lacking a GSK3 binding site. They then purified the
serine 45 kinase, and identified the 37 kDa protein as
CKIα. The CK1α binding site on Axin was consistent
with previous studies that had mapped the binding of
CK1ε to this same region [4,6,7]. Lui et al. [9] went on to
demonstrate that RNAi depletion of CKIα reduced the
level of serine 45 phosphorylation and upregulated the
level of β-catenin in 293T cells. Importantly, RNAi deple-
tion of CKIα in Drosophila embryos phenocopied the
effects of overexpressing the fly Wnt gene wingless.
Yanagawa et al. [10] used RNAi to explore the func-
tion of CKI in Drosophila Schneider S2R+ cells. They
found that depletion of either CKIε or CKIα led to
accumulation of the fly β-catenin Armadillo. Again,
RNAi in vivo led to a Drosophila phenotype consistent
with a negative regulatory role for CKI in Wingless sig-
naling. Further investigation, however, demonstrated
that stimulation with Wingless did not affect the
kinase activity of CKIα recovered from S2R+ cells. The
authors mapped the relevant sites of phosphorylation
by CKIα using stable cells expressing serine/threonine
mutants of Armadillo, as well as using the corre-
sponding peptides in vitro. It was apparent that muta-
tion of the Armadillo residue corresponding to serine
45 in β-catenin had a profound effect on its phospho-
rylation by CKIα. Surprisingly, mutation of acidic
residues  on the carboxy-terminal side of serine 45
also ablated phosphorylation by CKIα and again sta-
bilized Armadillo. This offers an explanation for some
previously inexplicable β-catenin mutations that were
identified in a subset of thyroid cancers [17].
Amit et al. [8] also used phosphorylation-specific
antibodies to identify sites of β-catenin phosphoryla-
tion following overexpression of Axin in 293 cells.
Expression of Axin alone triggered strong phospho-
rylation at serine 45, with only minor signals at serine
37 and serine 33, while coexpression of GSK3 greatly
enhanced the latter two signals. The precise location
of these phosphorylations was determined by mass
spectrometry. A point mutant of Axin incapable of
binding GSK3 still supported serine 45 phosphoryla-
tion, and a mutant GSK3 incapable of recognizing
primed substrates was unable to phosphorylate the
remaining sites. This agrees with an independent
observation [18] that this GSK3 mutant does not
induce β-catenin degradation in intact cells. Amit 
et al. [8] also identified GSK3α and GSK3β, as well as
CKIα, CKIδ and CKIε, by mass spectrometric analysis
of Axin immunoprecipitates. Together, these new
papers [8–10] leave little doubt that CKI is instrumen-
tal in the phosphorylation and targeted degradation
of β-catenin.
These new studies [8–10] turn the role for CKI in
Wnt signaling on its head, and have important impli-
cations for both basic biology and drug development.
Pharmacological inhibitors of CKI have been enter-
tained as anti-cancer prospects, but in the light of the
new data one would worry that they might actually
induce tumorigenesis. Also, the idea that modulation
of insulin signaling, but not of Wnt signaling, might be
achieved with GSK3 inhibitors selective for primed
substrates appears specious [15].
Finally, how can we reconcile the studies that
advance diametrically opposed roles for CKI in the
Wnt pathway? Perhaps there are models that accom-
modate both views. For example, CKI might enforce
the assembly of an Axin complex essential for trans-
mitting the Wnt signal (Figure 2). This is consistent
with data showing that phosphorylation of Dishevelled
by CKI promotes GBP binding [5]. CKI would thus
enhance the signal, effectively blocking GSK3, and
β-catenin would accumulate, despite its phosphoryla-
tion at serine 45. On the other hand, depleting endo-
genous CKI would preclude phosphorylation at serine
45, and β-catenin would again accumulate, this time 
in the absence of a Wnt signal. The binding of CKI 
to both Axin and Dishevelled, as well as its ability 
to phosphorylate Axin, APC, Dishevelled, TCF3 and
β-catenin, have all been reported [1–10,19]. Consider-
ing these myriad potential interactions, anything
seems possible.
References
1. Peters, J.M., McKay, R.M., McKay, J.P. and Graff, J.M. (1999).
Casein kinase I transduces Wnt signals. Nature 401, 345–350.
2. Sakanaka, C., Leong, P., Xu, L., Harrison, S.D. and Williams, L.T.
(1999). Casein kinase iepsilon in the Wnt pathway: regulation of
beta-catenin function. Proc. Natl. Acad. Sci. U.S.A. 96,
12548–12552.
3. Gao, Z.H., Seeling, J.M., Hill, V., Yochum, A. and Virshup, D.M.
(2002). Casein kinase I phosphorylates and destabilizes the beta-




Figure 2. A model with positive and negative roles for CKI in
Wnt signaling.
Phosphorylation of β-catenin at serine 45 by CK1 primes it for
subsequent phosphorylation by GSK3 at threonine 41, serine
37 and serine 33. The latter two phosphorylations are required
for β-TRCP binding that leads to the destruction of β-catenin.
CKI also phosphorylates Dishevelled, which is important for
GBP inhibition of GSK3 upon receipt of the Wnt signal.
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